サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1210911

ビグアナイドの世界市場規模調査・予測：タイプ別（メトホルミンIR、メトホルミンER、その他のビグアナイド）、剤形別（錠剤、溶液）、地域別分析、2022-2029年

Global Biguanides Market Size study & Forecast, by Type (Metformin IR, Metformin ER, Other Biguanide), By Dosage Form (Tablet and Solution) and Regional Analysis, 2022-2029

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.08円
ビグアナイドの世界市場規模調査・予測：タイプ別（メトホルミンIR、メトホルミンER、その他のビグアナイド）、剤形別（錠剤、溶液）、地域別分析、2022-2029年
出版日: 2023年01月25日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ビグアナイド系薬剤は、2型糖尿病の治療に使用される薬剤です。

消化の際に生じるグルコースの生成を抑えることで効果を発揮します。グルコファージ（メトホルミン）、グルコファージXR（メトホルミン徐放）、フォルタメット、グルメッツァ、リオメットが含まれます。ビグアナイド系薬剤の市場は、糖尿病患者の増加やヘルスケア支出の増加などの要因から拡大傾向にあります。

国際糖尿病連合（IDF）の2021年版によると、成人の糖尿病人口は5億3,700万人程度で、2030年には6億4,300万人に増加すると予想されています。肥満、不健康な食事、運動不足などが、新たに診断される1型および2型糖尿病患者数の増加につながっています。一方、技術革新や進歩、抗菌薬の使用量の増加により、市場には有利な機会が生まれています。しかし、代替品の脅威は、2022年から2029年の予測期間を通じて、市場成長を阻害しています。

世界のビグアナイド市場調査のために考慮された主要な地域は、アジア太平洋、北米、欧州、中南米、および世界のその他の地域が含まれています。アジア太平洋地域は、糖尿病患者の増加、抗薬剤の採用拡大、医療費の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、市場参入企業の増加や研究開発活動の活発化などの要因から、予測期間中に大きく成長することが見込まれています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメンテーション別市場推定・予測、2019年～2029年
    • ビグアナイド類市場：地域別、2019-2029年
    • ビグアナイド類市場：タイプ別、2019-2029年
    • ビグアナイド類市場：剤形別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 ビグアナイドの世界市場定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 ビグアナイドの世界市場力学

  • ビグアナイド類市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 糖尿病患者の増加
      • ヘルスケア支出の増加
    • 市場の課題
      • 代替品の脅威
    • 市場機会
      • 技術革新と進歩
      • 抗菌薬の使用量の増加

第4章 世界のビグアナイド系市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ビグアナイドの世界市場、タイプ別

  • 市場スナップショット
  • ビグアナイドの世界市場タイプ別実績-ポテンシャル分析
  • ビグアナイドの世界市場、タイプ別推定・予測2019-2029
  • ビグアナイド系薬剤の市場、サブセグメント別分析
    • メトホルミンIR
    • メトホルミンER
    • その他ビグアナイド

第7章：ビグアナイドの世界市場：剤形別

  • 市場スナップショット
  • ビグアナイドの世界市場：剤形別、実績-ポテンシャル分析
  • ビグアナイドの世界市場、剤形別推定・予測（2019-2029年
  • ビグアナイドの市場、サブセグメント分析
    • 錠剤
    • ソリューション

第8章 ビグアナイドの世界市場：地域別分析

  • ビグアナイドの世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2019年～2029年
      • 剤形別の推定・予測、2019年～2029年
    • カナダ
  • 欧州ビグアナイド市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域のビグアナイド系化合物市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのビグアナイド系市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Teva
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Merck
    • Takeda
    • GlaxoSmithKline
    • Sanofi
    • Boehringer Ingelheim Pharmaceuticals
    • Glenmark
    • AstraZeneca
    • Bristol-Myers Squibb
    • Aarti Drugs Ltd.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Biguanides Market, report scope
  • TABLE 2. Global Biguanides Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Biguanides Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Biguanides Market estimates & forecasts by Dosage Form 2019-2029 (USD Billion)
  • TABLE 5. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Biguanides Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Biguanides Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Biguanides Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Biguanides Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Biguanides Market
  • TABLE 70. List of primary sources, used in the study of global Biguanides Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Biguanides Market, research methodology
  • FIG 2. Global Biguanides Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Biguanides Market, key trends 2021
  • FIG 5. Global Biguanides Market, growth prospects 2022-2029
  • FIG 6. Global Biguanides Market, porters 5 force model
  • FIG 7. Global Biguanides Market, pest analysis
  • FIG 8. Global Biguanides Market, value chain analysis
  • FIG 9. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Biguanides Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Biguanides Market, regional snapshot 2019 & 2029
  • FIG 15. North America Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Biguanides Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Biguanides Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Biguanides Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Biguanides are medications used for the treatment of type 2 diabetes. It works by reducing the glucose production that occurs during digestion. It includes Glucophage (metformin) and Glucophage XR (metformin extended release), Fortamet, Glumetza, and Riomet. The Biguanides market is expanding because of factors such as the rising cases of diabetic patients and growing healthcare expenditure

According to International Diabetes Federation (IDF) 2021, the adult diabetes population will be around 537 million in 2021, rising to 643 million by 2030. Obesity, an unhealthy diet, and physical inactivity are all contributing to an increase in newly diagnosed Type 1 and Type 2 diabetes cases. Whereas rising technological innovations and advancement & growing usage of anti-biotic drugs create lucrative opportunities for the market. However, the threat of substitutes hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Biguanides Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. The Asia Pacific dominated the market in terms of revenue, owing to the increasing cases of diabetic patients, growing adoption of anti-drugs, and rising healthcare expenditure. Whereas the Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the growing penetration of market players and rising R&D activities.

Major market players included in this report are:

Teva

Merck

Takeda

GlaxoSmithKline

Sanofi

Boehringer Ingelheim Pharmaceuticals

Glenmark

AstraZeneca

Bristol-Myers Squibb

Aarti Drugs Ltd.

Recent Developments in the Market:

  • In July 2021, In India, the Drug Pricing Authority (NPPA) set retail prices for 84 drug formulations, including those used to treat diabetes, headaches, and high blood pressure. A single tablet of (SR) Metformin Hydrochloride will cost Rs 10.47, excluding GST, according to the order.
  • In July 2022, Glenmark Pharmaceuticals Limited has made sitagliptin and its Fixed Dose Combinations (FDCs) with metformin and other anti-diabetic drugs available at a low cost to adults with Type 2 diabetes. Each of these brands will have two variants: SITAZIT M (50 mg) + metformin (500 mg/1000 mg); SITAZIT M ER (100 mg) + metformin SR (500 mg/1000 mg). These medications have a low risk of hypoglycemia, protect beta cells, provide cardio-renal benefits, and are safe for patients with kidney or liver disease as well as seniors.

Global Biguanides Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Type, Dosage Form, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Metformin IR,

Metformin ER,

Other Biguanide

By Dosage Form:

Tablets

Solution

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Biguanides Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Biguanides Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Biguanides Market, by Dosage Form, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Biguanides Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Biguanides Market Dynamics

  • 3.1. Biguanides Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising cases of diabetic patients
      • 3.1.1.2. Growing healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Threat of substitute
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological innovations and advancements
      • 3.1.3.2. Growing usage of anti-biotic drugs

Chapter 4. Global Biguanides Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biguanides Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Biguanides Market by Type, Performance - Potential Analysis
  • 6.3. Global Biguanides Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Biguanides Market, Sub Segment Analysis
    • 6.4.1. Metformin IR,
    • 6.4.2. Metformin ER,
    • 6.4.3. Other Biguanide

Chapter 7. Global Biguanides Market, by Dosage Form

  • 7.1. Market Snapshot
  • 7.2. Global Biguanides Market by Dosage Form, Performance - Potential Analysis
  • 7.3. Global Biguanides Market Estimates & Forecasts by Dosage Form 2019-2029 (USD Billion)
  • 7.4. Biguanides Market, Sub Segment Analysis
    • 7.4.1. Tablets
    • 7.4.2. Solution

Chapter 8. Global Biguanides Market, Regional Analysis

  • 8.1. Biguanides Market, Regional Market Snapshot
  • 8.2. North America Biguanides Market
    • 8.2.1. U.S. Biguanides Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Dosage Form breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Biguanides Market
  • 8.3. Europe Biguanides Market Snapshot
    • 8.3.1. U.K. Biguanides Market
    • 8.3.2. Germany Biguanides Market
    • 8.3.3. France Biguanides Market
    • 8.3.4. Spain Biguanides Market
    • 8.3.5. Italy Biguanides Market
    • 8.3.6. Rest of Europe Biguanides Market
  • 8.4. Asia-Pacific Biguanides Market Snapshot
    • 8.4.1. China Biguanides Market
    • 8.4.2. India Biguanides Market
    • 8.4.3. Japan Biguanides Market
    • 8.4.4. Australia Biguanides Market
    • 8.4.5. South Korea Biguanides Market
    • 8.4.6. Rest of Asia Pacific Biguanides Market
  • 8.5. Latin America Biguanides Market Snapshot
    • 8.5.1. Brazil Biguanides Market
    • 8.5.2. Mexico Biguanides Market
  • 8.6. Rest of The World Biguanides Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Teva
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Merck
    • 9.2.3. Takeda
    • 9.2.4. GlaxoSmithKline
    • 9.2.5. Sanofi
    • 9.2.6. Boehringer Ingelheim Pharmaceuticals
    • 9.2.7. Glenmark
    • 9.2.8. AstraZeneca
    • 9.2.9. Bristol-Myers Squibb
    • 9.2.10. Aarti Drugs Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption